SE8504466D0 - Sett vid bestemning av lipoproteiner och apolipoproteiner - Google Patents

Sett vid bestemning av lipoproteiner och apolipoproteiner

Info

Publication number
SE8504466D0
SE8504466D0 SE8504466A SE8504466A SE8504466D0 SE 8504466 D0 SE8504466 D0 SE 8504466D0 SE 8504466 A SE8504466 A SE 8504466A SE 8504466 A SE8504466 A SE 8504466A SE 8504466 D0 SE8504466 D0 SE 8504466D0
Authority
SE
Sweden
Prior art keywords
pct
apolipoprotein
lipoprotein
date apr
denaturing
Prior art date
Application number
SE8504466A
Other languages
English (en)
Other versions
SE448324B (sv
Inventor
G B Jansson
S E Holmlund
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8504466A priority Critical patent/SE448324B/sv
Publication of SE8504466D0 publication Critical patent/SE8504466D0/sv
Priority to JP61505181A priority patent/JPS63501037A/ja
Priority to PCT/SE1986/000405 priority patent/WO1987002137A1/en
Priority to US07/049,997 priority patent/US4877746A/en
Priority to EP86905968A priority patent/EP0238614B1/en
Priority to AT86905968T priority patent/ATE58599T1/de
Priority to AU64039/86A priority patent/AU590340B2/en
Priority to DE8686905968T priority patent/DE3675763D1/de
Priority to CA000519195A priority patent/CA1280070C/en
Priority to ES8602242A priority patent/ES2002004A6/es
Publication of SE448324B publication Critical patent/SE448324B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SE8504466A 1985-09-27 1985-09-27 Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner SE448324B (sv)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8504466A SE448324B (sv) 1985-09-27 1985-09-27 Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner
DE8686905968T DE3675763D1 (de) 1985-09-27 1986-09-12 Testverfahren fuer lipoproteine und apolipoproteine.
EP86905968A EP0238614B1 (en) 1985-09-27 1986-09-12 Methods of carrying out assays for lipoproteins and apolipoproteins
PCT/SE1986/000405 WO1987002137A1 (en) 1985-09-27 1986-09-12 Methods of carrying out assays for lipoproteins and apolipoproteins
US07/049,997 US4877746A (en) 1985-09-27 1986-09-12 Methods of carrying out assays for lipoproteins and apolipoproteins
JP61505181A JPS63501037A (ja) 1985-09-27 1986-09-12 リポタンパク質及びアポリポタンパク質の測定方法
AT86905968T ATE58599T1 (de) 1985-09-27 1986-09-12 Testverfahren fuer lipoproteine und apolipoproteine.
AU64039/86A AU590340B2 (en) 1985-09-27 1986-09-12 Methods of carrying out assays for lipoproteins and apolipoproteins
CA000519195A CA1280070C (en) 1985-09-27 1986-09-26 Methods of carrying out assays for lipoproteins and apolipoproteins
ES8602242A ES2002004A6 (es) 1985-09-27 1986-09-26 Procedimiento para llevar a cabo el analisis inmunoquimico de lipoproteinas y-o apolipoproteinas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8504466A SE448324B (sv) 1985-09-27 1985-09-27 Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner

Publications (2)

Publication Number Publication Date
SE8504466D0 true SE8504466D0 (sv) 1985-09-27
SE448324B SE448324B (sv) 1987-02-09

Family

ID=20361533

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8504466A SE448324B (sv) 1985-09-27 1985-09-27 Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner

Country Status (9)

Country Link
US (1) US4877746A (sv)
EP (1) EP0238614B1 (sv)
JP (1) JPS63501037A (sv)
AU (1) AU590340B2 (sv)
CA (1) CA1280070C (sv)
DE (1) DE3675763D1 (sv)
ES (1) ES2002004A6 (sv)
SE (1) SE448324B (sv)
WO (1) WO1987002137A1 (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2627589B1 (fr) * 1988-02-24 1995-06-09 Pasteur Institut Procede immunoenzymometrique selectif pour le dosage de lipoproteines contenant de l'apob ou un fragment de celle-ci, anticorps monoclonaux anti-lp(a) et application au diagnostic de l'atherosclerose
JPH02242158A (ja) * 1989-03-15 1990-09-26 Nippon Shoji Kk ヒトアポリポ蛋白ｃ―３の測定法
US5168045A (en) * 1989-08-18 1992-12-01 The Scripps Research Institute Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
US5262303A (en) * 1989-10-13 1993-11-16 Trustees Of Boston University Ligand/anti-ligand assays for adherent proteins
US5149501A (en) * 1990-01-29 1992-09-22 Cirrus Diagnostics, Inc. Multichambered container and instrument for performing diagnostic tests
CA2052316C (en) * 1990-10-10 1997-12-23 Edward A. Oakley Sludge flow measuring system
WO1992009893A1 (en) * 1990-11-29 1992-06-11 Carbaugh John E DIAGNOSTIC AND THERAPEUTIC COMPOSITIONS AND METHODS FOR LIPOPROTEIN(a)
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
WO1992010760A1 (en) * 1990-11-30 1992-06-25 Monoclonetics International, Incorporated Methods for the diagnosis of chronic lower back and cervical pain
ATE183312T1 (de) * 1991-05-23 1999-08-15 Leo J Seman Jr Verfahren zur reinigung und detektion von lipoprotein (a) und assoziiertem cholesterol
US5733549A (en) * 1992-08-14 1998-03-31 Shino-Test Corporation Peptides including amino acid sequences selected from lipoprotein (a) and apolipoprotein (a), antibodies recognizing these amino acid sequences, and methods of determination using these antibodies
JP3370334B2 (ja) * 1993-09-29 2003-01-27 栄次 松浦 酸化リポタンパク質の測定法およびその用途
GB0001089D0 (en) * 2000-01-18 2000-03-08 Council Cent Lab Res Councils Lipoprotein assay
EP1357383B1 (en) 2002-04-09 2005-11-09 Cholestech Corporation High-density lipoprotein assay device and method
JP3600231B1 (ja) * 2003-09-30 2004-12-15 森永製菓株式会社 イムノアッセイ
DE602008002825D1 (de) 2007-01-09 2010-11-11 Cholestech Corp Vorrichtung und verfahren zur messung des ldl-assoziierten cholesterols

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829531A1 (de) * 1978-07-05 1980-01-24 Heuck Claus Christian Dr Rer N Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben
JPS58166263A (ja) * 1982-03-27 1983-10-01 Dai Ichi Pure Chem Co Ltd アポ蛋白ａ−ｉ標準品の調製法
DE3323949A1 (de) * 1983-07-02 1985-01-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
DE3533288A1 (de) * 1985-09-18 1987-03-26 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung von hdl-cholesterin im serum

Also Published As

Publication number Publication date
EP0238614B1 (en) 1990-11-22
AU590340B2 (en) 1989-11-02
AU6403986A (en) 1987-04-24
WO1987002137A1 (en) 1987-04-09
EP0238614A1 (en) 1987-09-30
CA1280070C (en) 1991-02-12
ES2002004A6 (es) 1988-07-01
DE3675763D1 (de) 1991-01-03
US4877746A (en) 1989-10-31
JPS63501037A (ja) 1988-04-14
SE448324B (sv) 1987-02-09

Similar Documents

Publication Publication Date Title
SE8504466D0 (sv) Sett vid bestemning av lipoproteiner och apolipoproteiner
SE8102558L (sv) Immunologisk bestemmningsmetod
DE3379116D1 (en) Immunoassay method
DE2963773D1 (en) Immunological determination process
ATE82072T1 (de) Immunoassay und -rolymere igg-derivate zur kompensation von stoerfaktoren in immunoassays.
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
DE69115267D1 (de) Antigen-/antiantigenspaltung.
ES8206856A1 (es) Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DE3779704D1 (de) Verfahren und testkit zur bestimmung freier wirkstoffe in biologischen fluessigkeiten.
DE59508474D1 (de) RHEUMAFAKTOR-ENTSTÖRUNG MIT ANTI-Fd-ANTIKÖRPERN
ATE105635T1 (de) Extraktionszusammensetzung, testsatz und deren verwendung zum nachweis von herpes-simplexantigen.
DE3781582D1 (de) Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion.
ATE42836T1 (de) Verfahren und reagenz zur quantitativen bestimmung von freiem thyroxin in plasma, serum oder vollblut.
DE3886403D1 (de) Verfahren zur Suche und Identifizierung von erythrozytären Antikörpern mit Hilfe der Festphasen-Methode.
ATE121197T1 (de) Immunometrisches verfahren zum nachweis von lipoprotein-teilchen, anti-lp(a) monoklonale antikörper und ihre anwendung zur diagnose von atherosklerose.
DE3569161D1 (en) Process for assaying atl virus antibody and reagent therefore
ATA261687A (de) Laktoferrin enthaltendes inkubationsmedium für festphasen-immunometrische verfahren und seine verwendung
ATE22997T1 (de) Verfahren zur immunologischen bestimmung, unter verwendung zweier antikoerper, wobei der zweite antikoerper durch affinitaetschromatographie gereinigt ist, und traeger dafuer.
DK608789A (da) Cea-immunanalyse uden falske positive foraarsaget af humant anti-museantistof
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
FI843562L (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
DE59007046D1 (de) Verfahren zum Nachweis von Analyten.
EP0096520A3 (en) Antigen detection: rheumatoid arthritis
OKURA et al. Immunological Study of the Soluble Proteins of Early Chick Embryos

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8504466-7

Effective date: 19880622

Format of ref document f/p: F